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Abstract
Malignant pheochromocytoma is a neuroendocrine tumor that originates from chromaffin tissue. Although osseous
metastases are common, metastatic dissemination to the spine rarely occurs.
Five years after primary diagnosis of extra-adrenal, abdominal pheochromocytoma and laparoscopic extirpation, a
53-year old patient presented with recurrence of pheochromocytoma involving the spine, the pelvis, both proximal
femora and the right humerus. Magnetic resonance imaging and computed tomography revealed osteolytic
lesions of numerous vertebrae (T1, T5, T10, and T12). In the case of T10, total destruction of the vertebral body
with involvement of the rear edge resulted in the risk of vertebral collapse and subsequent spinal stenosis. Thus,
dorsal instrumentation (T8-T12) and cement augmentation of T12 was performed after perioperative alpha- and
beta-adrenergic blockade with phenoxybenzamine and bisoprolol.
After thorough preoperative evaluation to assess the risk for surgery and anesthesia, and appropriate perioperative
management including pharmacological antihypertensive treatment, dorsal instrumentation of T8-T12 and cement
augmentation of T12 prior to placing the corresponding pedicle screws did not result in hypertensive crisis or
hemodynamic instability due to the release of catecholamines from metastatic lesions.
To the authors’ knowledge, this is the first report describing cement-augmentation in combination with dorsal
instrumentation to prevent osteolytic vertebral collapse in a patient with metastatic pheochromocytoma. With
appropriate preoperative measures, cement-augmented dorsal instrumentation represents a safe approach to
stabilize vertebral bodies with metastatic malignant pheochromocytoma. Nevertheless, direct manipulation of
metastatic lesions should be avoided as far as possible in order to minimize the risk of hemodynamic
complications.
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Background
Pheochromocytomas represent neuroendocrine tumors
that originate from catecholamine- producing chromaf-
fin tissues [1]. In 80-85% of cases, pheochromocytoma is
located in the adrenal gland [2]. Extra-adrenal location
of pheochromocytoma accounts for 15-20%, mostly aris-
ing from intraabdominal sympathetic ganglia (therefore
sometimes referred to as paraganglioma) [2]. The
reported incidence of pheochromocytoma ranges from
0.2 to 0.9 per 100,000 persons annually [1,2]. Malig-
nancy occurs in approximately 10-20% of the cases and
is defined by the presence of metastases and local inva-
sion rather than by histological criteria [3,4]. For malig-
nant pheochromocytoma, the 5-year survival rate is
reported to be up to 40% [1,5]. Malignant pheochromo-
cytoma is known to metastasize to bone, liver, lungs,
and lymph nodes. Although osseous metastases are
* Correspondence: clement.werner@usz.ch
1Division of Trauma Surgery, University Hospital Zurich, Switzerland
Full list of author information is available at the end of the article
Rittirsch et al. Patient Safety in Surgery 2012, 6:1
http://www.pssjournal.com/content/6/1/1
© 2012 Rittirsch et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.found prevalently, involvement of the spine is consid-
ered an exceptional rarity [6-10]. In this case report, the
authors present a strategy for operative stabilization of
metastatic pheochromocytoma of the thoracic spine
using dorsal instrumentation combined with cement
augmentation of the affected segments following preo-
perative alpha- and beta-adrenergic receptor blockade.
Case presentation
At the age of 48 years, the female patient presented with
paroxysmal severe headaches associated with hyperten-
sive peaks, pallor, and subsequent tremor. After labora-
tory testing and radiological imaging, the patient was
diagnosed with extra-adrenal pheochromocytoma
located retroperitoneally in the right ventro-lateral
region at the level of L2. The tumor was surgically
removed and the diagnosis was confirmed by histo-
pathological analysis. At that time, there was no evi-
dence for metastases neither to local lymph nodes nor
to remote tissues.
The patient remained asymptomatic for four years, but
then began to suffer from recurrent palpitations, par-
esthesia, headache, fatique, and flushing. These episodes
were accompanied by increased blood pressure levels
above 200/100 mmHg. Subsequent diagnostics revealed
recurrence of the pheochromocytoma in form of multi-
ple osseous metastases. The patient was admitted to the
hospital due to recurrent hypertensive crises and anti-
hypertensive medication was established by blockade of
alpha- (phenoxybenzamine) and beta-adrenergic recep-
tors (low-dose bisoprolol), and the calcium-channel
blocker dihydropyridine. A chemotherapy with a tyro-
sine kinase inhibitor (sunitinib) was initiated.
123Metaiodobenzylguanidine scan, magnetic resonance
imaging (MRI), and computed tomography (CT) scans
(Figure 1) revealed multiple osteolytic lesions of the
entire spine, especially prominent in T1, T5, T10, and
T12. Moreover, lesions were detected in the osseous
pelvis, both proximal femora, the right humerus, and
the left thoracic wall. In contrast, recurrence of the pri-
mary tumor in the right retroperitoneal lumbar region
was not detected. In the case of T10, CT and MRI scans
showed an instable fracture of the vertebral body with
entire destruction of the rear edge without spinal
obstruction and a pathologic fracture of the left pedicle
(Figure 1a, c). For T12, the CT scan revealed osteolytic
lesions in the center of the vertebral body and another
metastasis in proximity of the left pedicle (Figure 1d).
Thus, the indication for operative stabilization was given
to prevent the collapse of vertebral body T10 with con-
secutive spinal stenosis and spinal cord compression.
The patient’s typical symptoms consistent with pheo-
chromocytoma in the absence of recurrence of the pri-
mary tumor indicated endocrinological activity of the
metastases, implying a high risk for surgery and anesthe-
sia. Therefore, preoperative assessment besides ECG,
routine laboratory tests (electrolytes, kidney function
tests, complete blood count), and chest radiograph
included endocrinological evaluation (chromogranin A,
metanephrines, catecholamines) and transesophageal
echocardiography (TEE) for assessment of the patient’s
cardiac function. Furthermore, the antihypertensive
treatment was adjusted, aiming for full blood pressure
control with low normal values for at least one week,
absence of ST-segment elevations in ECG, and less than
one ventricular premature complex (VPC) over five
minutes in Holter ECG monitoring.
Eventually, the patient underwent surgery for stabiliza-
tion of the thoracic spine. After induction of general
anesthesia and intubation, the patient was placed in a
prone position for dorsal access to the lower thoracic
spine. For posterior approach, the paraspinal muscles
were detached subperiostally on each side after midline
longitudinal incision over the spinous processes. The
pedicle entry points of T8, T9, T11, and T12 were
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Figure 1 Computed tomography (CT) of the thoracic spine.
Sagittal (a) and coronary (b) CT scans revealing multiple osteolytic
lesions. c. Axial CT image of T10 depicting destruction of the rear
edge without spinal obstruction. d. Axial image of the CT scan of
T12 showing osteolytic lesions centrally and in proximity of the left
pedicle.
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(USS II, Synthes, Oberdorf, Switzerland) were placed
bilaterally in T8 and T9, followed by pedicle screw
insertion in T11. Since the patient did not react with
hemodynamic fluctuations to the placement of the
cephalad pedicle screws, cement-augmentation prior to
pedicle screw placement to T12 was employed. Likewise,
neither cement injection nor screw insertion resulted in
significant alterations of blood pressure or cardiac dys-
function. Visual control with an image converter showed
the optimal position of all pedicle screws so that the
screws were then connected by the transfixation rods
(USS II, Synthes) and the wound was closed in multiple
layers technique.
Postoperatively, the patient was referred to the ICU.
The further course was uneventful and the patient was
transferred to the regular ward on postoperative day
one. A CT scan after mobilization of the patient con-
firmed the correct position of the implants and showed
unaltered results for T10 with respect to vertebral body
height and spinal obstruction, and no signs of cement
extrusion at the segment of T12 (Figure 2). Following
wound healing, palliative chemotherapy with sunitinib
was restarted. In addition, the patient underwent
auxiliary radiation therapy after suture removal. As the
patient did not develop severe adverse effects to the
initial radiation therapy cycles she was discharged and
further monitored on an outpatient basis.
Discussion
Pheochromocytoma is a neuroendocrine tumor of the
medulla of the adrenal glands or extra-adrenal so-called
chromaffin tissue, which synthesizes and releases catecho-
lamines [1]. Although malignant pheochromocytoma is
known to metastasize prevalently to bones, involvement of
the spine is rather uncommon [6-10]. Thus, only a few
reports exist describing operative approaches of stabilizing
metastatic spinal pheochromocytoma and evidence-based
protocols for operative strategies and the preoperative
management are not available.
Since metastatic lesions from pheochromocytoma have
considerable potential to be endocrinologically active in
terms of producing, storing and secreting catecholamines
any type of surgical manipulation bears the risk of
unwanted release of catecholamines and consecutive
hemodynamic complications. For surgery of primary
pheochromocytoma, it has been shown that catecholamine
release can be triggered by direct manipulation during dis-
section/extirpation of the tumor and by increase of pres-
sure of the abdominal cavity, as it can occur by induction
of a pneumoperitoneum for laparoscopy or palpation of
the abdomen [11]. In addition to direct manipulation of
the tumor, application of cement may increase pressure
on the osseous metastatic lesion [12], and thereby cause
catecholamine release. Moreover, thermal necrosis of sur-
rounding tissue after cement application [13] might aggra-
vate catecholamine release. Therefore, the technique of
cement augmentation may bear an additional risk of
unwanted release of catecholamines, as compared to sim-
ple decompression/resection and instrumented fusion. On
the other hand, it is important for the stability and appro-
priate anchorage of pedicle screws that a mechanically
sound interface is created by cement augmentation. Other
factors that predispose to intraoperative hypertension
besides direct manipulation of the tumor include high nor-
epinephrine production, large tumor size (> 4 cm), a high
blood pressure at presentation and after alpha-adrenergic
receptor blockade (MAP > 100 mm Hg), and a pro-
nounced postural drop (>10 mm Hg) after alpha-receptor
blockade [14,15]. Interestingly, there are differences in
neurochemical and secretory phenotypes of catechola-
mine-producing tumors. In particular, tumors predomi-
nantly containing norepinephrine are characterized by
poorly differentiated secretory pathways resulting in unre-
gulated catecholamine release, in contrast to tumors that
predominantly produce epinephrine or metanephrine [16].
With respect to the risk of hemodynamic instability during
surgery of patients with pheochromocytoma, there are
a b 
c  d 
Figure 2 Postoperative computed tomography (CT) of the
thoracic spine. Sagittal (a) and coronary (b) CT scans after cement-
augmented dorsal instrumentation of T8-T12.
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tumor but not on the treatment of metastatic lesions. For
the pre-operative management, it has been shown that
alpha-receptor blockade has a significant impact on the
prevalence of perioperative complications (3% with block-
ade vs. 69% without alpha-adrenoceptor blockade; [17]).
However, there are no randomized prospective studies
that are large enough to establish the most effective drug
regimen before surgery. Traditional regimens include an
alpha-adrenergic receptor blockade prior to surgery with
phenoxybenzamine, prazosin or phentolamine to mini-
mize the risk of severe intraoperative hypertension [18].
Others suggest a combined alpha-/beta-adrenergic block-
ade to additionally prevent tachyarrhythmia [19]. In this
context, it is important to note that sole beta-adrenergic
blockade must not be employed since such treatment
might result in severe adverse effects, such as refractory
hypertension or acute myocardial necrosis due to unop-
posed alpha-adrenergic agonism [20,21]. Furthermore,
patients with pheochromocytoma should be considered to
be volume depleted because of a chronically elevated adre-
nergic state, which may lead to an inhibition of renin-
angiotensin activity, resulting in excessive fluid loss [22].
In the present case, phenoxybenzamine was administered
for non-specific, irreversible alpha-adrenergic blockade in
combination with low dose selective blockade of beta1-
receptors by bisoprolol.
With respect to the surgical procedure of metastatic
pheochromocytoma of the spine, several procedures
have been described, including laminectomy, surgical
debulking, pre-operative embolization, corporectomy
and reconstruction of the pathological vertebral body,
anterior plating, or combined anterior and posterior
stabilization of segments of the cervical spine
[6,9,10,23,24]. However, to the knowledge of the
authors, no reports exist describing dorsal stabilization
combined with cement-augmentation for metastatic
pheochromocytoma of the spine. Besides its primary
indication for the treatment osteoporotic vertebral
compression fractures, the use of cement in terms of
percutaneous vertebroplasty has been suggested as a
treatment option for spinal tumoral osteolysis. It has
been demonstrated that percutaneous vertebroplasty
provides immediate and long-term pain relief and
restores biomechanical stability of structurally wea-
kened vertebrae [25]. It can be combined with che-
motherapy, radiation therapy, tumor ablation, and
conventional surgical techniques [25]. Therefore, the
use of cement for the treatment of osteolytic spinal
lesions may represent a useful adjunct to the therapeu-
tic arsenal in the palliative treatment of spinal
metastases.
In the present case, cement injection into metastatic
lesions and subsequent insertion of the corresponding
pedicle screws did not result in significant fluctuations
of blood pressure or heart rate although the metastases
were considered to be hormonally active. The post-
operative treatment should be adjusted to the individual
patient situation, but adjuvant radiation therapy or com-
bined radiochemotherapy should be taken into consid-
eration as osseous lesions from pheochromocytoma tend
to respond well to radiation therapy [9,26,27].
Conclusion
Based on the anecdotal experience of the authors,
cement-augmented dorsal instrumentation represents a
safe approach for stabilization of metastatic pheochro-
mocytoma of the thoracic und lumbar spine. With
appropriate pretreatment (alpha- and beta-adrenergic
pharmacological blockade) and preoperative diagnostic
assessments the risk for hemodynamic instability can be
minimized. Nevertheless, unnecessary manipulation of
metastatic lesions should be omitted, not only to avoid
further dissemination of neoplastic cells, but, most
importantly, to prevent the unwanted release of catecho-
lamines and subsequent adverse hemodynamic
complications.
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